Ignite Creation Date:
2024-05-06 @ 12:35 PM
Last Modification Date:
2024-10-26 @ 1:01 PM
Study NCT ID:
NCT03794466
Status:
RECRUITING
Last Update Posted:
2023-08-01
First Post:
2019-01-03
Brief Title:
Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization
Sponsor:
University of Kansas Medical Center
Organization:
University of Kansas Medical Center
Study Overview
Official Title:
Quantification of Pain Relief With Gonadal Vein Embolization for Pelvic Congestion Syndrome
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment or poor response to treatment
Detailed Description:
Chronic pelvic pain affects almost 40 of women during their lifetime Pelvic congestion syndrome PCS accounts for up to 30 of those with chronic pelvic pain The most common underlying cause of PCS is incompetence or obstruction of the gonadal veins resulting in painful congestion of the pelvic and perineal venous vasculature Medical treatment is first line and aims to suppress ovarian function and induce vasoconstriction of the venous system Unfortunately efficacy and long-term pain relief from medical therapy is limited Coil embolization of the gonadal veins has been shown to decrease pain in those affected by PCS although the degree of relief has not yet been quantified
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None